Research and publications.
Six papers on home phlebotomy, decentralized trials and biospecimen handling, written by myOnsite's clinical research team with Mayank Trivedi.
Newest first.
- 2026
Mobile Cancer Screening Integrated with Employer-Sponsored Clinics to Improve Screening Compliance in Working Populations
Panchal H, Trivedi M
IJSMT 2(3), March 2026.
Sources: doi:10.55041/ijsmt.v2i3.040 (Mobile Cancer Screening Integrated with ) Full paper (PDF) (Mobile Cancer Screening Integrated with ) Summary on myOnsite (Mobile Cancer Screening Integrated with ) ResearchGate (Mobile Cancer Screening Integrated with )
- 2026
Mobile Phlebotomy in MASLD/MASH Clinical Trials: Enhancing Recruitment, Retention, and Data Integrity
Patel Y, Trivedi M
IJSR 15(2), February 2026.
Sources: doi:10.21275/SR26211102402 (Mobile Phlebotomy in MASLD/MASH Clinical)
- 2026
AI-Native Patient Recruitment and Decentralized Phlebotomy in Clinical Trials
Panchal H, Trivedi M
IJSR 15(2), February 2026.
Sources: Abstract on IJSR (paper SR26204233707) (AI-Native Patient Recruitment and Decent) Full paper (PDF) (AI-Native Patient Recruitment and Decent) Summary on myOnsite (AI-Native Patient Recruitment and Decent)
- 2026
Home Phlebotomy as Enabling Infrastructure for Cancer Care at Home and Decentralized Clinical Trials
Panchal H, Trivedi M
World Journal of Advance Pharmaceutical Sciences, 2026.
- 2025
Standardization in Clinical Trials: Optimizing Biospecimen Collection, Preservation, and Export
Panchal H, Trivedi M
IJRIAS 10(11):782–793, December 2025.
Sources: doi:10.51584/IJRIAS.2025.101100073 (Standardization in Clinical Trials: Opti) Paper on the IJRIAS site (Standardization in Clinical Trials: Opti) Full paper (PDF) (Standardization in Clinical Trials: Opti) Summary on myOnsite (Standardization in Clinical Trials: Opti)
- 2025
Advancing Oncology Trials Through Home Phlebotomy: A Comprehensive Review of Patient-Centered Outcomes
Panchal H, Trivedi M
IJRTI 10(9):a46–a54, September 2025.
Sources: Full paper (PDF, paper IJRTI2509005) (Advancing Oncology Trials Through Home P) Summary on myOnsite (Advancing Oncology Trials Through Home P) ResearchGate (Advancing Oncology Trials Through Home P)
IJSR describes itself as a double-blind peer-reviewed journal (IJSR website). For the other journals, read each journal's own review policy before citing a paper as peer reviewed.
Written by Memorial Sloan Kettering clinicians.
Bange et al. studied home phlebotomy delivered by myOnsite for 345 cancer patients. JNCI Cancer Spectrum, 2024;8(6):pkae104.
The numbers, the one target it missed and the limits its authors state are on the Impact page.